These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37132021)

  • 1. Non-cirrhotic Portal Hypertension as the Initial Presentation of Limited Cutaneous Scleroderma: A Case Report.
    Hitawala AA; Redmond C; Cowen EW; Kleiner DE; Hasni S; Heller T
    J Investig Med High Impact Case Rep; 2023; 11():23247096231171251. PubMed ID: 37132021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of idiopathic portal hypertension accompanying multiple hepatic nodular regenerative hyperplasia in a patient with systemic sclerosis.
    Yamamoto A; Matsuda H; Hiramatsu K; Tsuji A; Midori Y; Murata Y; Tanaka T; Tohda G; Nosaka T; Takahashi K; Naito T; Ofuji K; Ohtani M; Imamura Y; Nakamoto Y
    Clin J Gastroenterol; 2021 Jun; 14(3):820-826. PubMed ID: 33886104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver transplantation in precirrhotic biliary tract disease: Portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathy.
    Abraham SC; Kamath PS; Eghtesad B; Demetris AJ; Krasinskas AM
    Am J Surg Pathol; 2006 Nov; 30(11):1454-61. PubMed ID: 17063088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obliterative portal venopathy without portal hypertension: an underestimated condition.
    Guido M; Sarcognato S; Sonzogni A; Lucà MG; Senzolo M; Fagiuoli S; Ferrarese A; Pizzi M; Giacomelli L; Colloredo G
    Liver Int; 2016 Mar; 36(3):454-60. PubMed ID: 26264219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatoportal sclerosis (obliterative portal venopathy) and nodular regenerative hyperplasia in a patient with myasthenia gravis: A case report and review of the published work.
    Agrawal M; Rahmani R; Nakkala K; Fiel MI; Schiano T
    Hepatol Res; 2013 Sep; 43(9):999-1003. PubMed ID: 23675894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-cirrhotic portal hypertension - diagnosis and management.
    Khanna R; Sarin SK
    J Hepatol; 2014 Feb; 60(2):421-41. PubMed ID: 23978714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Case of Non-cirrhotic Portal Hypertension With Antiphospholipid Syndrome.
    Shah M; Gill R; Hotwani P; Moparty H; Kumar N; Gala D; Kumar V
    Cureus; 2024 Feb; 16(2):e53843. PubMed ID: 38465021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Living donor liver transplantation for idiopathic portal hypertension with extrahepatic portal vein stenosis and splenic artery aneurysms: a case report and review of the literature.
    Kawachi S; Chiba N; Nakagawa M; Kobayashi T; Hikita K; Sano T; Tomita K; Hirano H; Abe Y; Obara H; Shimazu M
    BMC Surg; 2020 Oct; 20(1):257. PubMed ID: 33121468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and clinical significance of nodular regenerative hyperplasia in liver biopsies.
    Barge S; Grando V; Nault JC; Broudin C; Beaugrand M; Ganne-Carrié N; Roulot D; Ziol M
    Liver Int; 2016 Jul; 36(7):1059-66. PubMed ID: 26415006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-cirrhotic portal hypertension.
    Sarin SK; Khanna R
    Clin Liver Dis; 2014 May; 18(2):451-76. PubMed ID: 24679506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obliterative portal venopathy: a clinical and histopathological review.
    Aggarwal S; Fiel MI; Schiano TD
    Dig Dis Sci; 2013 Oct; 58(10):2767-76. PubMed ID: 23812828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-cirrhotic portal hypertension: an imaging review.
    Rajesh S; Mukund A; Sureka B; Bansal K; Ronot M; Arora A
    Abdom Radiol (NY); 2018 Aug; 43(8):1991-2010. PubMed ID: 29564495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathology of idiopathic non-cirrhotic portal hypertension.
    Guido M; Sarcognato S; Sacchi D; Colloredo G
    Virchows Arch; 2018 Jul; 473(1):23-31. PubMed ID: 29644430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porto-sinusoidal Vascular Disease and Portal Hypertension.
    Noble S; Linz M; Correia E; Shalaby A; Bittencourt LK; Sclair SN
    Clin Liver Dis; 2024 Aug; 28(3):455-466. PubMed ID: 38945637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-cirrhotic portal hypertension (obliterative portal venopathy) is the predominant form of chronic liver disease in cystic fibrosis.
    ONeill JP; Clifford CS; Nolan NP; McCormick PA
    Ir J Med Sci; 2023 Aug; 192(4):1657-1660. PubMed ID: 36114932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Porto-sinusoidal vascular disorder.
    De Gottardi A; Sempoux C; Berzigotti A
    J Hepatol; 2022 Oct; 77(4):1124-1135. PubMed ID: 35690264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of systemic sclerosis complicated by idiopathic portal hypertension: case report and literature review.
    Takagi K; Nishio S; Akimoto K; Yoshino T; Kawai S
    Mod Rheumatol; 2006; 16(3):183-7. PubMed ID: 16767559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of endothelial-mesenchymal transition in idiopathic portal hypertension.
    Sato Y; Nakanuma Y
    Histol Histopathol; 2013 Feb; 28(2):145-54. PubMed ID: 23275299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant von Willebrand factor expression of sinusoidal endothelial cells and quiescence of hepatic stellate cells in nodular regenerative hyperplasia and obliterative portal venopathy.
    Zhang X; Thomas C; Schiano TD; Thung SN; Ward SC; Fiel MI
    Histopathology; 2020 Jun; 76(7):959-967. PubMed ID: 31994248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-cirrhotic portal fibrosis (idiopathic portal hypertension): experience with 151 patients and a review of the literature.
    Dhiman RK; Chawla Y; Vasishta RK; Kakkar N; Dilawari JB; Trehan MS; Puri P; Mitra SK; Suri S
    J Gastroenterol Hepatol; 2002 Jan; 17(1):6-16. PubMed ID: 11895549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.